Is Aquestive Therapeutics, Inc. (AQST) a Buy, Sell, or Hold?
Aquestive Therapeutics, Inc.
NASDAQ:AQST
$3.95 USD
-$0.09 (-2.23%)
- Volume
- 1.89M
- Average Volume
- 1.81M
- Market Capitalization
- $392.26M
- P/E Ratio
- -6.48
- Dividend Yield
- 0.00%
- Price Target
- $9.00
- Year High
- $7.55
- Year Low
- $2.93
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $4.10
CCURRENT INSTITUTIONAL OWNERSHIP PERCENTAGE
1.16%
Investors Holding
8
change: -178 | last: 186
Increased Positions
2
change: -103 | last: 105
Reduced Positions
0
change: -48 | last: 48
New Positions
0
change: -49 | last: 49
Sold Positions
172
change: 119 | last: 53
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: -34.5175 | last: 0.3452
Total Invested
5.92M
AQST Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $6.46 | 121.97M | $787.91M | $121.17M | $131.44M | $798.18M |
| 2024-12-31 | $3.56 | 86.73M | $308.75M | $71.55M | $38M | $275.2M |
| 2023-12-31 | $2.02 | 61.26M | $123.74M | $23.87M | $33.32M | $133.18M |
| 2022-12-31 | $0.90 | 48.73M | $43.96M | $27.27M | $57.49M | $74.18M |
| 2021-12-31 | $3.89 | 38.08M | $148.12M | $28.02M | $56.42M | $176.52M |
| 2020-12-31 | $5.35 | 33.65M | $180.03M | $31.81M | $40.48M | $188.7M |
| 2019-12-31 | $5.82 | 25.36M | $147.57M | $49.33M | $60.34M | $158.58M |
| 2018-12-31 | $6.30 | 20.73M | $130.57M | $60.6M | $47.2M | $117.17M |
| 2017-12-31 | $16.05 | 20M | $321M | $17.38M | $45.51M | $349.13M |
| 2016-12-31 | $16.05 | 24.5M | $393.22M | $9.21M | $38.65M | $422.67M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4.15 | 122.61M | $508.83M | $110.73M | $133.58M | $531.68M |
| 2025-12-31 | $6.46 | 121.97M | $787.91M | $121.17M | $131.44M | $798.18M |
| 2025-09-30 | $5.59 | 110.58M | $618.17M | $129.06M | $128.86M | $617.97M |
| 2025-06-30 | $3.31 | 99.33M | $328.77M | $60.54M | $40.26M | $308.49M |
| 2025-03-31 | $2.90 | 95.5M | $276.94M | $68.66M | $39.14M | $247.42M |
| 2024-12-31 | $3.56 | 91.2M | $324.67M | $71.55M | $38M | $291.13M |
| 2024-09-30 | $4.98 | 91.08M | $453.59M | $77.89M | $36.87M | $412.56M |
| 2024-06-30 | $2.45 | 90.91M | $222.73M | $89.87M | $35.72M | $168.59M |
| 2024-03-31 | $4.13 | 73.61M | $304.03M | $95.2M | $34.48M | $243.31M |
| 2023-12-31 | $2.02 | 68.53M | $138.44M | $23.87M | $33.32M | $147.88M |
| 2023-09-30 | $1.53 | 64.68M | $98.96M | $24.92M | $45.04M | $119.08M |
| 2023-06-30 | $1.65 | 57.35M | $94.63M | $22.44M | $45.12M | $117.31M |